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Abstract
Background: We investigated the net changes in prevalence of symptoms of asthma and rhinitis over 10 years in a
cohort of young by baseline sensitization status.
Methods: One thousand one hundred ninety three Chilean adults subjects aged 22–28 living in a semi-rural area of
central Chile answered a lifestyle and the European Community Respiratory Health Survey (ECRHS) questionnaires.
Bronchial hyper-responsiveness (BHR) and skin prick test (SPT) to eight allergens were measured at baseline in 2001.
Ten years later, 772 participants completed the questionnaires again. Estimates of adjusted net changes in prevalence
of symptoms by sensitization status at baseline and association between sensitization status at baseline and respiratory
symptoms ten years later were assessed.
Results: A quarter of the participants were sensitized to at least one allergen in 2001. Prevalence of wheeze had a net
change per year of −0.37 % (95 % Confidence Interval −0.71 to 0.02 %; p = 0.067). Self-reported nasal allergies in the
last 12 months increased by 0.83 % per year (95 % CI 0.49 to 1.17 %; p < 0.001). Those sensitized to either cat fur (OR 1.
76; CI 1.01 to 3.05), cockroach, (OR 2.09; 1.13 to 3.86) blend of grass and pollens (1.78; 95 % CI 1.08 to 2.92), or weeds
(OR 1.77; 95 % CI 1.01 to 3.12) in 2001 were more likely to have wheeze in the last 12 months 10 years later.
Conclusion: Symptoms of asthma remained stable or slightly changed over 10 years in adults, whilst rhinitis and nasal
allergies greatly increased. Being sensitized to at least one allergen is a risk factor for persistent symptoms of asthma
and rhinitis, but not for determining net changes of symptoms over time. The underlying causes for the contrasting
trends between asthma and nasal allergy are unknown.
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Background
Countries with emerging and fast growing economies
have similar prevalence of asthma to developed coun-
tries [1, 2]. In Chile, the prevalence of asthma in chil-
dren is 22 % [1] whilst in adults it ranges between 16
and 28 % depending on the epidemiological approaches
used to measure it [3, 4].
Longitudinal studies on changes of asthma symptoms,
nasal allergy and sensitization are scant, with most of
the evidence coming from European countries. The
follow-up analysis of the European Community Respira-
tory Health Survey (ECRHS) cohort showed that adults
aged 25–49 were more likely to have symptoms of
asthma at 10 year follow-up if they were sensitized to
pets at baseline [5]. Similarly, another longitudinal study
in Italian adults showed that sensitization to indoor al-
lergens was associated with having a higher prevalence
of symptoms ten years later [6]. A higher prevalence of
respiratory symptoms was also observed at follow-up in
other two studies with selected samples from existing
cohort studies [7, 8]. The ECRHS has also shown that
symptoms of asthma have remained stable over time in
middle aged adults [9]. However, the ECRHS results, the
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main body of evidence, need to be replicated to know
the extent to which they conform a general pattern.
The Limache (Chile) Cohort study started in 2001 with
the aim of identifying early life and current risk factors for
asthma in young adults from a semi-rural area [10]. In
2011, we examined this cohort again to study respiratory
symptoms using the ECRHS questionnaire [11]. This
follow-up study allows an assessment of the evolution of
symptoms of the disease over time. The aims of this study
were to investigate the net changes in prevalence of respira-
tory symptoms and nasal allergies within a period of ten
years in a cohort of young adults, according to sensitization
status based on skin prick test (SPT) to eight allergens. We
also aimed to assess whether the sensitization status in
2001 were still related to asthma and rhinitis 10 years later
(in 2011).
Methods
Sample
The Limache Cohort study was set up in 2001 with the
aim of investigating early and current environmental risk
factors for asthma in young adults. This is part of a non-
concurrent longitudinal study aimed to assess risk fac-
tors in early childhood and in young adults for asthma
and poor lung function [10]. A simple random sample of
1,232 subjects was obtained for our initial respiratory
disease study based on statistical power estimates using
the effects of birth weight differences on lung function
as outcome for the respiratory study. Those who could
not be included in the study because of death, emigra-
tion (11.3 %), serving a custodial sentence, disability or
lactation (3.3 %) and unwillingness to participate (7 %)
were randomly replaced using the same sampling frame.
This decision was taken at protocol stage and was de-
signed to maintain statistical power for hypothesis test-
ing, an important consideration in prospective studies.
Ten years later, 796 individuals were traced and enrolled
in the follow-up study. The random selection of partici-
pants, and attrition at baseline and at follow-up are
shown in Fig. 1.
Outcome measures
We measured lung function (including bronchial hyper-
responsiveness [BHR]), respiratory symptoms, and allergy
in the 2001 study. Information on respiratory symptoms
and related risk factors was also collected. In 2011, par-
ticipants were contacted again and invited to answer a
detailed questionnaire on socio-economic background, life-
style and respiratory symptoms. In both periods, 2001 and
2011, information on the following asthma symptoms was
ascertained using a translated version of the ECRHS ques-
tionnaire [11]: “Have you had wheezing or whistling in your
chest at any time in the last 12 months?”, “Have you ever
had asthma?”, “Has a doctor diagnosed you with asthma?
Sampling frame of live births  registered in Limache between 1974-1978
N=3,092
Participants replaced (n=305)
Sampling 2001
N=1,232
Participant loss (attrition) (n=305) due to:
• Refusal to participate (n=86) 
• Death (n=39)
• Emigrated (n=139)
• Other reasons i.e. pregnancy, severe illness,  
mental disability, custodial sentence (n=41)
Final sample in survey 2001
N=1,232
Attrition (n=460) due to:
• Refusal to participate (n=29) 
• Death (n=6)
• Emigrated (n=166; 22 to another country)
• Address unavailable (n=116) 
• Participant traced but unavailable for contact 
after repeated visits (n=115) 
• Incomplete data at follow-up relevant to this 
analysis (n=28) 
Final sample studied at follow-up (2011)
N=772
Fig. 1 Flow chart of sample selection and attrition in the Limache Cohort (2001 – 2011)
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Has a doctor given you advice or treatment for asthma”
and “Have woken up at night with shortness of breath in
the last 12 months”? The question “Have you had any nasal
allergies, including rhinitis in the last 12 months?” was used
to estimate nasal allergy and rhinitis. We used the Spanish
version of the ECHRS questionnaire that replaced “hay
fever” by “rhinitis”, as “hay fever” would not have been
understood by most participants in the general population
in Spanish speaking countries including Chile.
The tidal breathing method with increasing concentra-
tions of methacholine (0.5, 1.00, 4.00, 8.00 and 16 mg/
ml) was used to assess BHR to methacholine challenge
at baseline only (in 2001) [12]. BHR was expressed as a
continuous measure, the least squares concentration-
response slope, analogous to dose-response slope [13].
SPT (measured at baseline only) to the following eight
allergens (supplied by Allergy Therapeutics): D pteronys-
sinus, cat fur, dog hair, Alternaria alternata, cockroach,
a mixture of grass pollens considered the main contribu-
tors of pollen in the air in Santiago [14], a mixture of
weeds and shrubs, and a mixture of trees. Histamine was
used as the positive control and an uncoated Phazet as the
negative control. A SPT was positive if the wheal mean
diameter was 3 mm or greater. The reference group for al-
lergic status was comprised of those with a negative SPT
to all allergens at baseline (n = 559). Subjects were consid-
ered atopic if they had a positive reaction to any of the al-
lergens tested. Sensitization status was categorized as
firstly as ‘sensitization to at least 1 allergen’ (i.e. the partici-
pant could have one or more positive sensitization), to give
the overall effect of sensitization, and the other three
groups to assess whether there was an increasing associ-
ation between positive reactions to allergens and each of
the symptoms studied, as follows: 1) ‘sensitization to
one allergen (any)’ (i.e. the participant has a single posi-
tive sensitization to any one allergen), 2) sensitization
to 2 allergens, and 3) sensitization to 3 or more aller-
gens. In the analysis the reference group were those
with no sensitization to any of the eight allergens.
Body weight was recorded using a standard beam bal-
ance scale, with subjects standing barefoot and wearing
light clothing [15].
Statistical analyses
Generalized estimating equations (GEE) using equal cor-
relation model were applied to estimate the longitudinal
change in the prevalence of symptoms in the population
[16] adjusting for gender, age, BMI (continuous), smok-
ing status (current, ex-smoker, never smoker) and atopy
(positive to at least one of the eight allergens). GEEs were
also used to estimate net changes in prevalence of asthma
stratified by the risk factors gender, smoking status, atopy,
and response to methacholine challenge and examined un-
adjusted and adjusted by the variables in the model. The
longitudinal association between sensitization status at
baseline (2001) and net changes in the prevalence of self-
reported respiratory symptoms at follow-up were exam-
ined using logistic regression controlling for potential
confounders. We added a weighting factor to all analyses to
account for the attrition of the cohort between phases 1
and 2 of the cohort study. This factor is based on the recip-
rocal of the probability of losses, which considers the differ-
ences between participants and non-participants [17].
The STATA package version 13.0 was used for statis-
tical analyses.
Results
The sample distribution of respiratory symptoms reported
in 2001 and 2011, and related risk factors are presented in
Table 1. There was an attrition rate of 35 % (n = 421). 772
individuals had complete data in both surveys. The distri-
bution of smoking was similar to that found in 2001, with
a decrease in the proportion of current smokers over the
10 year period (Table 1). The prevalence of reported
‘wheeze in the last 12 months’ decreased 2 % in men and
5 % in women, whilst the prevalence of ‘doctor diagnosed
asthma’ increased slightly in both groups. ‘Woken at night
with shortness of breath’ increased by 5 % in males and
remained stable in women (Table 1).
We investigated the level of bias of the sample in
2011 by comparing the characteristics of participants
and non-participants in the follow-up study based on
2001 results, with no differences between participants
and non-participants in 2001 (data on Additional file 1:
Table S1).
The adjusted net changes of respiratory and allergic
symptoms are presented in Table 2. The prevalence of
wheeze decreased 3.4 % over ten years, whilst other
asthma-related symptoms showed a slight increase, though
none of these were statistically significant (Table 2). The
net change of nasal allergies was statistically significantly
positive (0.8 % per year; 95 % CI 0.47 to 1.18). As current
wheeze is the most commonly investigated symptom to as-
certain current asthma, we also investigated the pattern of
change stratified by potential modifiers (Table 3). Regard-
less of smoking status, wheeze decreased over 10 years,
but the decrease in each group was not significant, al-
though the group of ex-smokers was too small for infer-
ence when adjusted for covariates. A reduction in the net
change prevalence of current wheeze was observed in
those with a negative BHR response, or no atopy, as well
as in those who had nasal allergies (Table 3).
Sensitization at baseline to either Dermatophagoides
pteronyssinus, cat fur, cockroach, blend of grass and mix-
ture of weeds or shrubs in 2001 was associated with
wheeze in the last 12 months and ever had asthma in
2011 (Table 4). Only a mix of tree allergens was associ-
ated with woken by shortness of breath in the last
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12 months in 2011. Nasal allergies in 2011 were positively
related to most allergens in the unadjusted models in
2001, but it was not any longer significant for cockroach,
dog hair and Alternaria Alternata in the adjusted model
(Table 4). In the analysis assessing generic sensitization,
having wheeze in the last 12 months, ever asthma, or nasal
allergies in 2011 were related to being sensitized to at least
one allergen in 2001 (Table 5). There was no increasing
trend of association between the number of sensitizations
in 2001 and prevalence of any of the symptoms in 2011,
but the association was strongest for ever-asthma in those
sensitized to three or more allergens. Waking with breath-
lessness in 2011 was not associated with sensitization in
2001 (Table 5).
Discussion
In this prospective study of young adults, we found an
eight per cent net increase over a ten-year period in self-
reported rhinitis and nasal allergies, a borderline signifi-
cant decrease in the prevalence of wheeze in the last
12 months, and an increase of Dr diagnosed asthma and
waking up with shortness of breath in the last 12 months.
Sensitization to cat fur, cockroach, blend of grass and
pollens, or mixture of weeds or shrubs at baseline was
associated with wheeze in the last 12 months ten years
later. Baseline sensitisation to Dermatophagoides ptero-
nyssinus, cat fur, and blend of grass was associated with
ever asthma in 2011. Most allergens at baseline were
also associated with having nasal allergies in 2011.
Our finding of an eight per cent increase of rhinitis
and nasal allergy in 10 years was consistent to the multi-
centric ECRHS study finding of a net increase of 7 %
over a 10 years follow-up [9]. Both studies demonstrated
a net increase in Dr. diagnosed asthma of over 1.4 % in
Table 2 Net changes in prevalence of symptoms of asthma,
diagnosed asthma and nasal allergy including rhinitis between
2001 and 2011
Respiratory outcome N (%) in 2001 Net change per
year % (95 % CI)a
Wheeze in the last 12 months 327 (27.4) −0.34 (−0.71 to 0.02)
Ever had asthma 55 (4.6) 0.06 (−0.06 to 0.02)b
Doctor diagnosed asthma 49 (4.1) 0.15 (−0.004 to 0.30)c
Woken by shortness of breath
in the last 12 months
165 (13.8) 0.25 (−0.06 to 0.57)
Nasal allergies including rhinitis
in the last 12 months
200 (16.8) 0.82 (0.47 to 1.18)b
aAdjusted for gender, age, BMI, smoking and atopy
bBMI not controlled for due to non-convergence when included
cBMI, age and smoking not controlled for due to non-convergence
when included
Table 1 Sample distribution of respiratory symptoms and related risk factors in the Limache Cohort in 2001 and 2011
Variables Survey year 2001
N = 1,193
Survey year 2011
N = 772
Males Females Male Female
N = 544 (45.6 %) N = 649 (54.4 %) N = 282 (36.5 %) N = 490 (63.5 %)
Age (years) mean (SD) 24.9 (1.6) 24.7 (1.6) 35.4 (2.2) 35.1 (2.0)
Smoking status (%) Never 129 (23.7) 253 (39.0) 73 (21.8) 176 (35.8)
Ex-smokers 48 (8.8) 77 (11.9) 22 (26.1) 107 (21.8)
Current 367 (67.5) 319 (49.1) 148 (52.1) 208 (42.4)
Weight (kg) Median (IQR) 70.1 (63.0–77.9) 61.5 (54.9–70.0) 77.9 (69.5–86.5) 69.1 (61.4–78.3)
Adult height (cm) Mean (SD) 168.1 (6.1) 156.4 (5.5) 168.6 (4.9) 156.9 (6.2)
BMI (kg/m2) Median (IQR) 24.7 (22.6–27.2) 25.1 (22.6–28.6) 27.3 (24.6–30.1) 28.2 (25.4–31.6)
Wheeze in the last 12 months 26.3 28.4 22.7 23.1
Ever had asthma (%) 3.1 5.9 3.9 7.1
Dr diagnosed asthma (%) 2.6 5.4 3.9 7.1
Woken by shortness of breath in the last 12 months (%) 10.7 16.5 14.2 18.0
Nasal allergies including rhinitis in the last 12 months (%) 10.5 22.0 18.4 30.8
At least 1 asthma symptom and nasal allergies (n, %)a 36 (63 %) 82 (58 %) 27 (52 %) 79 (53 %)
Positive skin prick test (SPT) to at least one allergen (data obtained in 2001) (%) 26.7 26.4 28.7 26.9
Positive response to methacholine (data obtained in 2001) (%) 7.9 16.0 7.5 16.9
Educational level achieved
Primary 126 (23.1) 120 (18.5) 69 (24.5) 106 (21.6)
Secondary 290 (53.3) 348 (53.6) 159 (56.4) 269 (54.9)
Higher 128 (23.5) 181 (27.9) 54 (19.2) 115 (23.5)
aProportion from the total of people reporting having nasal allergies including rhinitis in each group
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the same period. Similarly, both studies demonstrated
no significant changes in wheeze and other self-
reported symptoms, although there was a borderline
significant trend towards a decrease of wheeze in our
study. A possible explanation for the stability of symp-
toms over time might be related to an improvement in
the diagnosis and management of asthma in recent
years. However, this is an unlikely explanation in our
study, as Limache and Olmue have limited medical re-
sources and given the socio economic status of the par-
ticipants in our study, not many participants could
afford treatment elsewhere. In our assessment of possible
modifiers we found that ex-smokers, non-sensitized
participants and those with a positive nasal allergy
were significantly associated to a decrease in wheeze.
A decrease in wheeze is plausible in ex-smokers, but
this group is too small to influence the trend in the
total sample.
Allergic rhinitis is increasing worldwide [18] and rep-
resents a major economic burden for the healthcare sys-
tem. A nine per cent increase in these young adults is of
public health relevance as a high prevalence of allergic
rhinitis is associated with significant occupational absen-
teeism. In our study, allergic rhinitis increased in both
sexes, possibly because of an increasing temporal trend
of the disease [19]. Asthma increased in women, as ex-
pected according to population ageing.
Prospective changes in asthma in population based
studies have usually been described as incidence and re-
mission [20–23], with reports of the latter ranging be-
tween 5 and 40 % in adults, or up to 70 % in children
[21], depending on the period of follow-up and the def-
inition of remission used [24]. In a postal survey, Ekerl-
jung and colleagues found that the 10-year remission of
wheeze in the last 12 months was 14.6 % in subjects
with asthma aged 20–69 years [21] whilst Bronnimann
and colleagues reported remission rates ranging from
70 % in children to 10 % in young adults after 10 years
of follow-up [22]. Contrasting trends in nasal allergies
(increasing) and asthma (stable) have also been observed
in Northern Italy with repeated cross-sectional surveys
[25]. Our study adds to knowledge by demonstrating
that the increase of nasal allergies is occurring not only
between individuals over time, but also within individ-
uals. We decided not to estimate incidence because a
lack of symptoms of asthma at baseline does not pre-
clude the possibility that a participant may have previ-
ously had such a symptom and also because of the
possibility of information bias in the responses at each
survey. Such eventualities would have provided inaccur-
ate incidence estimates. The small net increase of 1.4 %
in the proportion of adults answering ‘yes’ to the doctor
diagnosed asthma question might indicate a slight in-
crease in the diagnosis of asthma in Limache over a
10 year period. Such small increase might also be a re-
flection of better diagnostic skills of asthma in the area.
Based on the Tucson Epidemiologic Study [26] we would
have expected rhinitis to be an independent risk factor
for onset asthma and to influence the trajectory of
wheeze over 10 years. However, this was not the case in
this adult population.
Symptoms of asthma severity were very infrequent
and therefore excluded from our analyses. This may hap-
pen because of the limited health care resources avail-
able in a semi-rural area. This was one of the reasons
why we focused analysis in the question ‘waking up at
night with shortness of breath’. This symptom has been
used with other questions to estimate asthma severity
Table 3 Changes in prevalence of wheeze in the last 12 months 2001–2011 stratified by potential modifiers
Stratification Category N (%) in 2001 Unadjusted net change %
(95 % confidence Interval)
Adjusted net change %
(95 % confidence Interval)
Gendera Males 143 (26.3) −0.16 (−0.71 to 0.39) −0.27 (−0.81 to 0.27)
Females 184 (28.4) −0.59 (−1.08 to −0.10) −0.48 (−0.96 to −0.004)
Smoking statusb Never smoker 39 (17.6) −0.25 (−0.81 to 0.31) −0.35 (−0.95 to 0.24)
Continuous smoker 115 (36.4) −0.22 (−0.85 to 0.40) −0.22 (−0.83 to 0.39)
New smoker (started after 2001) 9 (26.5) −0.45 (−2.88 to 2.00) −0.58 (−2.95 to 1.79)
Ex-smoker (gave up after 2001) 5 (21.7) −2.00 (−2.91 to −1.02) convergence not achieved
Atopic status (SPT)c Positive 111 (35.1) −0.28 (−1.10 to 0.51) −0.26 (−1.03 to 0.51)
Negative 216 (24.6) −0.43 (−0.84 to −0.02) −0.41 (−0.82 to −0.003)
Methacholine challengec Positive 57 (38.8) −0.48 (−1.57 to 0.62) −0.27 (−1.41 to 0.88)
Negative 270 (25.8) −0.37 (−0.76 to 0.01) −0.39 (−0.76 to −0.01)
Nasal allergies including rhinitis
in last 12 monthsc
Positive 98 (49.0) −1.90 (−2.96 to −0.84) −1.90 (−3.00 to −0.83)
Negative 229 (23.1) −0.10 (−0.49 to 0.28) −0.10 (−0.46 to 0.28)
aAdjusted model included the confounders smoking, SPT, and methacholine challenge
bAdjusted model included the confounders gender, SPT, and methacholine challenge
cAdjusted model included the confounders gender, and smoking
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Table 4 Risk of asthma symptoms and nasal allergies in 2011 according to allergic status at baseline (2001)a
Allergic status in 2001 (positive SPT) Symptoms reported in 2011 (n)
Wheeze in the last
12 months (n = 182)
OR (95 % CI)
Ever had asthma
(n = 48)
OR (95 % CI)
Woken by shortness of breath in
the last 12 months (n = 131)
OR (95 % CI)
Nasal allergies including
rhinitis (n = 205)
OR (95 % CI)
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Dermatophagoides Pteronyssinus (n = 213) 1.59 (1.05–2.40) 1.31 (0.84–2.05) 3.41 (1.82–6.36) 2.49 (1.06–5.85) 1.38 (0.86–2.21) 1.38 (0.85–2.25) 3.41 (2.31–5.03) 3.56 (2.35–5.40)
Cat fur (n = 117) 1.86 (1.12–3.10) 1.76 (1.01–3.05) 3.54 (1.73–7.24) 2.95 (1.15–7.53) 1.53 (0.85–2.75) 1.52 (0.87–2.66) 2.52 (1.54–4.11) 1.88 (1.12–3.13)
Dog hair (n = 67) 1.66 (0.86–3.20) 1.47 (0.72–2.98) 3.59 (1.54–8.34) 1.53 (0.79–2.95) 2.06 (1.02–4.16) 1.93 (0.94–3.97) 2.36 (1.27–4.48) 1.73 (0.88–3.38)
Cockroach (n = 97) 2.21 (1.26–3.85) 2.09 (1.13–3.86) 1.77 (0.71–4.41) 1.16 (0.39–3.51) 1.41 (0.72–2.77) 1.30 (0.65–2.58) 1.36 (0.77–2.40) 1.31 (0.70–2.43)
Alternaria alternata (n = 63) 1.13 (0.55–2.34) 1.00 (0.48–2.09) 2.09 (0.76–5.69) 1.67 (0.64–4.35) 1.09 (0.47–2.55) 1.07 (0.47–2.42) 2.31 (1.21–4.36) 1.94 (0.99–3.79)
Blend of grass and pollensb (n = 162) 1.96 (1.24–3.08) 1.78 (1.08–2.92) 2.67 (1.34–5.33) 2.94 (1.11–7.79) 1.32 (0.77–2.24) 1.29 (0.75–2.19) 2.44 (1.58–3.77) 2.40 (1.49–3.80)
Mixture of weeds and shrubsc (n = 119) 1.67 (0.99–2.82) 1.77 (1.01–3.12) 2.53 (1.20–5.56) 2.38 (0.80–7.12) 1.03 (0.54–1.96) 1.10 (0.59–2.10) 2.01 (1.22–3.31) 1.84 (1.08–3.13)
Tree (n = 122) 1.36 (0.81–2.29) 1.08 (0.61–1.92) 2.11 (0.96–4.60) 1.24 (0.46–3.33) 1.91 (1.10–3.30) 1.98 (1.12–3.50) 2.63 (1.64–4.25) 2.40 (1.44–3.99)
aAdjusted models included the following potential confounders: by age, gender, smoking status, BMI, years of school, and for the same symptom in 2001
bOats grass, crested dogstail, cocksfoot, rye grass, meadow grass, vernal bent, brome, meadow foxtail, Timothy, meadow fescue, Yorkshire fog
cWeeds mixture included Mugwort, fat hen, ouche, nettle, and plantain, and the mixture of trees included birch, beech, oak-common, alder, ash, hazel, poplar, plane, elm, and willow
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Table 5 Risk of asthma symptoms and nasal allergies in 2011 by combined sensitization status at baseline (2001)
Allergic status in 2001 (positive SPT) Symptoms reported in 2011 (n) OR 95 % CIa
Wheeze in the last 12 months
(n = 182)
Ever had asthma
(n = 48)
Woken by shortness of breath
in the last 12 months (n = 131)
Nasal allergies including
rhinitis (n = 205)
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Sensitized to at least 1 allergen (n = 316) 1.96 (1.36–2.82) 1.73 (1.17–2.55) 2.84 (1.54–5.24) 3.28 (1.43–7.53) 1.52 (1.00–2.29) 1.47 (0.96–2.25) 3.34 (2.36–4.74) 3.32 (2.30–4.80)
Sensitized to 1 allergen (any) 1.36 (0.87–2.13) 1.27 (0.79–2.05) 1.56 (0.71–3.45) 1.84 (0.70–4.83) 0.92 (0.54–1.57) 0.88 (0.52–1.48) 2.44 (1.60–3.71) 2.56 (1.64–4.02)
Sensitized to 2 allergens 2.29 (1.24–4.21) 2.23 (1.15–4.32) 1.63 (0.53–5.00) 1.83 (0.41–8.22) 1.27 (0.61–2.67) 1.38 (0.64–2.95) 5.01 (2.78–9.06) 5.32 (2.81–10.10)
Sensitized to 3+ allergens 1.62 (0.94–2.79) 1.45 (0.81–2.60) 4.10 (1.88–8.89) 3.74 (1.22–11.46) 1.45 (0.79–2.64) 1.55 (0.85–2.83) 3.52 (2.11–5.87) 3.67 (2.08–6.47)
aAdjusted by age, gender, smoking status, BMI, years of school, and for the same symptom in 2001
Those who were negative to the eight allergens formed the reference group
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[27], but we found no evidence of association between
waking with shortness of breath and between wheeze, and
sensitization at baseline, in contrast to rhinitis or nasal al-
lergy in 2011. This finding highlights the need to investi-
gate the accuracy of the responses to the question waking
up at night with shortness of breath in the general popula-
tion, especially in rural and semi-rural areas in intermedi-
ate development countries. We found no association
between having a positive BHR at baseline and changes in
asthma symptoms at follow-up, which might suggests that
changes in asthma prevalence could be related to other
environmental exposures in this population.
Atopy has been linked to the development of asthma
in children and adults [28]. We found a higher risk of
having wheeze in the last 12 months and that of ever
having asthma in young adults who were sensitized to
Dermatophagoides Pteronyssinus, cat, cockroach, pollen,
or trees in 2001. These associations remained statisti-
cally significant when using 2011 data after adjusting for
sensitization status at baseline, which suggests that aller-
gens might contribute to persistence of asthma symp-
toms. Sensitization played a more important role for the
symptoms “nasal allergies including rhinitis” in the fol-
low up study, as reflected by the high odds ratios. Con-
trary to another epidemiological study [29] we did not
observe that being sensitized to multiple allergens was
associated with higher risk of current wheeze.
Specific sensitization in the etiology and persistence of
asthma has been shown in relation to several allergens.
Dermatophagoides Pteronyssinus, one of the most com-
monly distributed indoor allergens, has been proposed as
having the strongest causal association with asthma symp-
toms in adults [30]. A small longitudinal study looking at
BHR showed that after a 4 year period sensitization to
house dust mite was a risk factor for more broncho-
reactivity to BHR, whilst exposure to cat fur was not asso-
ciated to measures of asthma, including BHR [29]. In our
study cat fur but not dog hair was found to be associated
with asthma and rhinitis symptoms. Cat dust is known to
be a potent allergen with a high concentration of Fel d1
and d4 [31, 32], it is also lighter in weight than dog’s dust,
which means it stays in the environment for a longer
period, which might partly explain our findings. Furred pet
allergens are also passively transferred from one environ-
ment to another [32]. The combination of widespread ex-
posure to cat allergens and high prevalence of sensitization
to cat suggests that a substantial proportion of individuals
with asthma are at risk for cat allergen-induced asthma
symptoms. In fact, several studies have directly linked ani-
mal allergen exposure to poorer asthma outcomes among
animal-sensitized patients with asthma [33].
The strengths of our study were the use of a compre-
hensive range of allergens and the BHR assessment at
baseline, the use of an internationally validated and
standardized questionnaire to assess symptoms of
asthma and related risk factors and a satisfactory re-
sponse rate of 65 % over a 10-year period. We also
added a weighting factor to allow for the losses observed
at follow-up. The area where the study took place is
mainly devoted to agriculture and tourism, with a low
industrial infra-structure, low road traffic, far from big
cities and the Andes (i.e. not locked inside mountains)
that allows for a lower accumulation of air pollutants
than that observed in the capital, Santiago [34]. These
factors make us suggest that the air pollution is not a
major problem, in spite of the agricultural and touristic
growth of the area. Measurement error is inherent to
longitudinal studies, and can lead to biases in the esti-
mates of asthma rates. We attempted to reduce this risk
of bias by reporting net changes.
A caveat of our study is that we based the definition of
asthma on self-reported symptoms only. Although these
are relatively reliable as a proxy for asthma in epidemio-
logical studies, data on BHR at follow-up was not avail-
able. The sample size of the study was not sufficiently
large for subgroup analysis of those that stop smoking
between 2001 and 2011.
Conclusion
In a cohort study of young adults, symptoms of asthma
remained stable over a 10-year period. Our results suggest
that sensitization to common allergens plays a role in the
reporting of asthma symptoms and rhinitis 10 years later,
but are not good predictors of asthma symptoms. This
longitudinal study has demonstrated a marked increase in
nasal allergy and rhinitis within individuals in contrast
with a stable or small decrease of wheeze over a 10 years
period. The underlying causes for these contrasting trends
are worth studying.
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